Cmed Announces Appointment of New Vice President of Commercialisation and Operations for Timaeus
Cmed advances commercial development of its award-winning Timaeus system, with the appointment of a new global head of commercialisation and operations that has extensive experience both in enterprise software production and biopharma business transformation.
Horsham, UK - March 3rd 2010 - Cmed announced today the appointment of James Haughwout as Vice President of Commercialisation and Operations for Timaeus, its award-winning electronic data capture and management system. Over the past 17 years, James has produced software and information systems used globally by more than 130 million people and 400 enterprises. In addition, he brings expertise combining business process reengineering with advanced technologies within the biopharma industry to transform capabilities in clinical data and submissions management.
“We are delighted to welcome James Haughwout to Cmed,” said David Connelly, Cmed CEO. “His proven marketing, technical and operations leadership in both the commercial software and biopharma sectors will be instrumental to the advancement of Timaeus and our Cmed Technology company. We also believe his background in business transformation will be particularly helpful in developing partnerships with systems integrators and consultancies—better enabling our clients to realise the next-generation benefits of Timaeus.”
“I am tremendously excited to be joining Cmed,” said James. “Over the course of my career, I have been privileged to work with some amazing technologies. However, I have seen few companies take such a truly groundbreaking approach as Cmed did when they developed Timaeus. As a result, it enables investigators, clinical nurses, monitors, data managers and study managers to capture and manage data from all over the world in ways I have not seen possible anywhere else. I look forward to helping Cmed and their clients succeed through use of Timaeus.”
About Cmed Group Ltd
For pharmaceutical, biotech and research organizations that need to accelerate the right medicines to market, Cmed Group is an innovative clinical trials company that specializes in providing state-of-the-art technology products and diverse services. Unlike separate eClinical technology and contract research organization (CRO) vendors, Cmed Group takes a flexible and efficient approach in providing the right solution that meets our customers’ changing needs and expectations. As a result, Cmed Group expedites clinical trials operations to provide immediate real-world results for clinical trial sponsors through its companies: Cmed Clinical Services, a full-service CRO, and Cmed Technology, an eClinical technology provider. For further information visit www.cmedgroup.com
###
